Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
WTF is AI poisoning?
LLM search results have become an important channel for marketers. They’re also a conduit for rivals to sow misinformation against a brand’s online profile.
Agency bosses say the AI gap with clients is only getting wider
The more versions of this perspective that got shared, the more it became clear there was a deeper frustration underneath it from others.
Electronic Arts is betting that in-game ads can out-earn CTV
To make in-game ads stick, EA has built its own stack rather than rent one. Now it wants to shape the standards before anyone else does.